Alligator Bioscience

Annual General Meeting 2023
2023-05-26

Interim report January - March 2023
2023-04-25

Extraordinary General Meeting 2023
2023-04-24

European Bispecific & Multispecific Antibody Congress
2023-02-22 - 2023-02-23 | Amsterdam, Amsterdam, Nederländerna
Laura von Schantz, Vice President of Discovery at Alligator Bioscience, will give a presentation entitled “Reviewing the Landscape of Obligate MoAs for Bi-/Multispecifics to Prioritise and De-Risk Current and Future Efforts” at 2.30 pm CET on February 22.

ØU Life Science Investor Conference
2023-02-22 | Köpenhamn, Köpenhamn, Danmark
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.

Year-end report January-December 2022
2023-02-10

Aktiespararna "Aktiedagen i Lund"
2023-01-31 | Elite Hotel Ideon, Scheelevägen 27, Lund, Sverige

Redeye Fight Cancer Day 2023
2023-01-19 | Redeye, Mäster Samuelsgatan 42, Stockholm, Sverige

41st Annual J.P. Morgan Healthcare Conference
2023-01-09 - 2023-01-12

13th Annual DNB Nordic Healthcare Conference
2022-12-15 | Oslo, Oslo, Norge

Biostock Life Science Fall Summit 2022
2022-11-30 13:00 - 13:30 (Europe/Stockholm) | Medicon Village, Medicon Village, Lund, Sverige
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will give a corporate presentation followed by a Q&A session at 1:00 pm CET on November 30.

Redeye Life Science Day, Stockholm
2022-11-24 | Virtuellt

Jefferies London Healthcare Conference 2022
2022-11-15 - 2022-11-17 | London, London, Storbritannien (Förenade kungariket Storbritannien)

SITC (Society for Immunotherapy of Cancer) 2022
2022-11-08 - 2022-11-12 | Boston, Boston, Massachusetts, Förenta Staterna, USA
Malin Lindstedt, visiting professor at Alligator Bioscience and Professor at the Department of Immunotechnology at Lund University, will give a poster presentation entitled “Early pharmacodynamic changes measured by RNA sequencing in peripheral blood from patients in a phase 1 study with mitazalimab, a potent CD40 agonistic IgG1 monoclonal antibody”, poster number 35, on November 10.
Ana Carneiro, Associate Professor and Consultant at Lund University, will give a poster presentation entitled “ATOR-1017, a 4-1BB antibody, demonstrates promising safety and proof of mechanism in a first-in-human study in patients with advanced solid malignancies”, poster number 714, on November 11.

Festival of Biologics
2022-11-02 - 2022-11-04 | Basel, Schweiz
Mattias Levin, PhD, Senior Team Manager, Antibody Engineering, at Alligator Bioscience, will give a presentation entitled “Neo-X-Prime™: Bispecific Tumor Antigen Conditional CD40 Agonistic Antibodies” at 5:00 pm CET on November 3.

Interim report January-September 2022
2022-10-20

Interim report January - June 2022
2022-07-12

Tumor Myeloid-Directed Therapies Summit
2022-06-14 - 2022-06-16 | Boston, Boston, Massachusetts, Förenta Staterna, USA

2022 BIO International Convention in San Diego
2022-06-13 - 2022-06-16 | San Diego, San Diego, California, Förenta Staterna, USA

BioStock Life Science Spring Summit
2022-06-08 - 2022-06-09

ASCO Annual Meeting 2022
2022-06-03 - 2022-06-07 | Chicago, Chicago, Illinois, Förenta Staterna, USA

Redeye Growth Day
2022-06-02

Annual General Meeting 2022
2022-05-05

Interim report January - March 2022
2022-04-27

Year-end report 2021
2022-02-11

Interim report July - September 2021
2021-10-21

SITC (Society for Immunotherapy of Cancer) 2019
2019-11-06 - 2019-11-10 | National Harbor, Maryland, National Harbor, Maryland, Förenta Staterna, USA
34th Annual Meeting, National Harbor, USA

Interim report July - September 2019
2019-10-24

Festival of Biologics, Basel
2019-10-15 - 2019-10-17 | Basel, Schweiz

Investing in Oncology Forum 2019, Stockholm
2019-10-07 | Stockholm, Stockholm, Sverige
Read more about the event and register here:
http://cordcom.se/oncology-forum-2019.
